In the wake of Dobbs, physicians who specialize in women’s health were more likely to vote in the midterms than their peers, according to new research from Binghamton University, State University of New York. 

A new study has uncovered a previously overlooked pathway linking road traffic pollution and cultivated crops. While plant uptake of tire wear-derived contaminants was already known, this study is among the first to show under environmentally realistic conditions that tire wear particles themselves act as short- and long-term sources of contamination, gradually released into soil. The research demonstrates that tire particles released due to tire abortion do not simply accumulate in the environment as microplastics; they also serve as reservoirs of toxic additives that may be released into the agricultural systems and potentially enter the food chain. The findings, published in Environmental Research, provide new insight into how everyday road traffic may contribute to contaminant exposure through food production.

Eight EU-funded research consortia warn that Europe risks a crisis if it fails to halt pollinator loss. Their solution: a roadmap to reverse wild pollinator decline and protect managed bees.

The United States still leads China in the quality and commercial reach of its biomedical science but is losing the race to translate scientific discoveries into cures. New analyses from the Cure Innovation Index, released today ahead of Cure's session on U.S.-China biomedical competitiveness at the BIO International Convention in San Diego, find that without immediate renewed investment and policy changes, the U.S. scientific edge will not hold. “America’s challenge is no longer discovery alone. The emerging battleground is translation, the speed and efficiency with which scientific breakthroughs move from the laboratory into development, commercialization, and patient impact," said Seema Kumar, CEO of Cure, the premier healthcare innovation ecosystem headquartered in New York City. If the United States wants to stay ahead, the answer isn't to out-publish China. It's to fix the translational bottlenecks with renewed funding, especially for early translational work, modernized clinical trial infrastructure, and stronger bridges between academic research and industry.